Robert W Holloway

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Locally Advanced

Endometrial Cancer

Squamous Cell Carcinoma

Neoadjuvant Chemotherapy

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

JCO oncology practice

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Theresa M Kuhn, Sarfraz Ahmad, Fernando O Recio, Ahmad Awada, Nathalie D McKenzie, James E Kendrick, Andrew Keller, Robert W Holloway
Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Theresa M Kuhn, Sarfraz Ahmad, Fernando O Recio, Ahmad Awada, Nathalie D McKenzie, James E Kendrick, Andrew Keller, Robert W Holloway
Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (7) (2024)
Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Crafton, Erin Crane, Eskander Ramez, Sharad Ghamande, Whitney Graybill, Thomas Herzog, Megan Dr Indermaur, Veena S John, Lisa Landrum, Peter C Lim, Joseph A Lucci, Michael McHale, Bradley J Monk, Kathleen Nadine Moore, Robert Morris, David M O'Malley, Thomas J Reid, Debra L Richardson, Peter G Rose, Jennifer M Scalici, Dan-Arin Silasi, Krishnansu Tewari, Edward W Wang
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (9) (2023)
Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Crafton, Erin Crane, Eskander Ramez, Sharad Ghamande, Whitney Graybill, Thomas Herzog, Megan Dr Indermaur, Veena S John, Lisa Landrum, Peter C Lim, Joseph A Lucci, Michael McHale, Bradley J Monk, Kathleen Nadine Moore, Robert Morris, David M O'Malley, Thomas J Reid, Debra L Richardson, Peter G Rose, Jennifer M Scalici, Dan-Arin Silasi, Krishnansu Tewari, Edward W Wang
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (9) (2023)
Kofi Sefah, Karolina A Kilowski, Sarah A Gifford, Angela Grove, Jon Shaffer, Baylee Bryan, Sarfraz Ahmad, Robert W Holloway
Standardized Titration Protocol Reduces the Incidence of Paclitaxel Infusion-Related Hypersensitivity Reactions. JCO oncology practice (2023)
Lara C Burg, Shenna Verheijen, Ruud L M Bekkers, Joanna IntHout, Robert W Holloway, Salih Taşkın, Sarah E Ferguson, Yu Xue, Antonino Ditto, Glauco Baiocchi, Andrea Papadia, Giorgio Bogani, Alessandro Buda, Roy F P M Kruitwagen, Petra L M Zusterzeel
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis. Journal of gynecologic oncology 33 (5) (2022)